NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: SCHOTT North America

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

SCHOTT and Hungarian Government Invest in Cutting-edge Syringe Production - The company is planning to build an entirely new production for high-quality prefillable glass syringes (PFS) in Hungary - SCHOTT.com
SCHOTT and Hungarian Government Invest in Cutting-edge Syringe Production

 

NewswireTODAY - /newswire/ - Lukácsháza, Hungary, 2022/03/10 - The company is planning to build an entirely new production for high-quality prefillable glass syringes (PFS) in Hungary - SCHOTT.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

• The 76 million Euro (28,044 billion HUF) investment in Hungary is designed to meet the growing global demand for prefillable syringes made of glass.
• The brand new production is planned at SCHOTT’s existing site in Lukácsháza.

In light of the growing demand for drug delivery solutions, the international technology group SCHOTT is again investing in its pharma business: The company is planning to build an entirely new production for high-quality prefillable glass syringes (PFS) in Hungary. “The added capacity will greatly benefit the global market and strengthen supply security for major pharmaceutical companies and contract manufacturing organizations,” said Andreas Reisse, Executive Vice President of SCHOTT’s Pharma business unit. The double-digit million Euro amount is supported by the local government with about nine million Euros (3,321 billion HUF). The expansion is scheduled for completion in 2024 and is designed to create 120 new jobs.

The drug containment and delivery solution is an integral part of every medication. Typically, a new drug enters the market in a vial and a single-use syringe is used to extract and administer it. In the mid-to-long term, these drugs may be stored in syringes that are prefilled with the medication. This simplifies the injection process for healthcare workers and increases dosing accuracy for the patient, as the syringe is already readily prepared. “High-quality prefillable syringes are designed to ease the administration process, ultimately enhancing patient safety,” explains Christian Helbig, Head of Glass Syringes at SCHOTT’s Pharma business unit. “Our borosilicate glass PFS are used to safely store a wide range of drugs, including vaccines and biologics.”

Already today, SCHOTT’s Hungarian site in Lukácsháza plays an important role in supplying the global industry with drug containment systems and provides enough space for further capacity expansions to follow.

Building on the strong existing foundation and skillset, the production will be equipped with state-of-the-art machinery. As part of SCHOTT’s global production network in 13 countries, the manufacturing will follow high-end processes and advanced quality assurance.

Trademarks:
syriQ® is a registered trademark of SCHOTT AG.

Pioneering responsibly together
These attributes characterize SCHOTT (schott.com) as a manufacturer of high-tech materials based on specialty glass. Founder Otto Schott is considered its inventor and became the pioneer of an entire industry. Always opening up new markets and applications with a pioneering spirit and passion this is what has driven the #glasslovers at SCHOTT for more than 130 years. Represented in 34 countries, the company is a highly skilled partner for high-tech industries: Healthcare, Home Appliances & Living, Consumer Electronics, Semiconductors & Datacom, Optics, Industry & Energy, Automotive, Astronomy, and Aerospace. In the fiscal year 2021, its 17,300 employees generated sales of 2.5 billion euros (US$ 3.0 billion). SCHOTT AG is owned by the Carl Zeiss Foundation, one of the oldest foundations in Germany. It uses the Group's dividends to promote science. As a foundation company, SCHOTT has anchored responsibility for employees, society and the environment deeply in its DNA. The goal is to become a climate-neutral company by 2030.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: SCHOTT North America

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


SCHOTT and Hungarian Government Invest in Cutting-edge Syringe Production

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
syriQ® | SCHOTT AG
Contact: Rina Della Vecchia - SCHOTT North America, Inc. 
914-831-2286 rina.dellavecchia[.]us.schott.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any SCHOTT North America securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From SCHOTT North America / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Bruker Introduces Next-Generation 3D Areal Surface Measurement Technology for Production and Research Environments
Endress+Hauser Announces Expansion to its Laboratory Sensor Portfolio 
TRUMPF and RSP Systems Partner to Make Blood Glucose Monitoring Easier for People with Diabetes
Bruker Announces Acquisition of ACQUIFER Imaging GmbH
Withings Announces U-Scan - The World’s First Hands-free Connected Home Urine Lab
In Vitro Fertilization Services Industry to be Boosted by Innovative Technologies According to Frost & Sullivan
Magnetic Resonance Imaging Market to Witness Growth Due to Increasing Demand for Scans Says Frost & Sullivan
Frost & Sullivan Recognizes VitalConnect with the 2022 New Product Innovation Award for its Leading-edge Wearable Patient Monitoring Device
SmartCardia Earns Frost & Sullivan’s 2022 Global New Product Innovation Award in the Cardiac-monitoring Wearables Industry
Atlas Copco Acquired A Chinese Manufacturer of Medical Oxygen Solutions
Cardiac Troponin Diagnostics Market Growth Boosted by High-sensitivity Point-of-care Testing Says Frost & Sullivan
Bruker Announces Acquisition of Inscopix for Neuroscience Research
hemotune Applauded by Frost & Sullivan for Enabling Selective and Efficient Extraction of Large Compounds from Blood with its Purification Platform
MediView Medical Monitor and New 23.8' MediClient Variant Complement Kontron's Medical Technology Portfolio
Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape® 2023 Software

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  Sublime SEO





 
  ©2005-2023 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)